The server is under maintenance between 08:00 to 12:00 (GMT+08:00), and please visit later.
We apologize for any inconvenience caused
Login  | Sign Up  |  Oriprobe Inc. Feed
China/Asia On Demand
Journal Articles
Laws/Policies/Regulations
Companies/Products
Bookmark and Share
Effect of pirarubicin in repeated transurethral resection of non-muscle invasive bladder cancer
Author(s): 
Pages: 649-652
Year: Issue:  11
Journal: World Clinical Drugs

Keyword:  膀胱癌吡柔比星二次经尿道膀胱癌电切术;
Abstract: 膀胱癌是常见的泌尿系统恶性肿瘤之一,行常规经尿道膀胱癌电切术(TURBT)加术后膀胱内化疗药物灌注,复发率及进展率较高.目前主张在行经尿道膀胱癌电切术后4周内再次行该术式,但仍有较大盲目性.吡柔比星具有抗癌谱广、被肿瘤细胞选择性吸收后在膀胱镜下形成橙色染色区等特性,用于膀胱癌治疗尤其是在二次电切术治疗中,不但能杀死肿瘤细胞,还具有示踪作用,可作为膀胱灌注药物的首选,临床应用前景广.
Related Articles
No related articles found